Korean Rosuvastatin Effectiveness Study in Nondiabetic Metabolic Syndrome
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to compare the effect of rosuvastatin 10mg with
atorvastatin 10mg in the percentage reduction of LDL-C in Subjects with metabolic syndrome
after 6 weeks of treatment.